Disclaimer

Effective Date: July 2, 2026 · Last Updated: July 2, 2026

Cannabis Investor News ("CIN") is an independent research publication operated by CanIDeal, Inc. This disclaimer summarizes the terms under which CIN content is provided. Read alongside our Editorial Standards, Methodology, Terms of Service, and Privacy Policy.

1. Not Investment Advice

Nothing published on Cannabis Investor News constitutes investment advice, a recommendation to buy or sell any security, an offer to sell or a solicitation of an offer to buy any security, or personalized financial, tax, legal, or accounting advice. All content is provided for informational and educational purposes only.

CIN is not registered with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (FINRA), any state securities regulator, or any foreign securities regulator as an investment adviser, broker-dealer, or fiduciary. Nothing on this site should be interpreted as a personal recommendation for you, your portfolio, or your circumstances. Consult a licensed financial adviser, tax professional, and securities attorney before making any investment decision.

2. Independence & Analyst Disclosures

CIN is editorially independent from every company it covers. We do not accept payment, equity, options, warrants, tokens, or other consideration from covered companies, their officers, agents, or affiliates in exchange for coverage, favorable framing, timing, or omission. We do not publish sponsored articles disguised as editorial. Any advertising, if displayed, is clearly labeled and does not influence editorial selection, framing, or ranking.

Cannabis Investor News is operated by CanIDeal, Inc. CanIDeal operates a B2B cannabis marketplace and does not trade cannabis equities. Joseph Farruggia, CIN's founder and lead analyst, does not hold long or short positions in any of the 326 tickers in CIN's coverage universe. If this ever changes for any specific company covered in a CIN piece, that position will be disclosed inline on the relevant page prior to publication.

CIN contributors, if any, are required to disclose material relationships with covered companies before publication. Any such disclosure appears inline on the relevant page.

3. Regulatory Status

Joseph Farruggia is an independent research analyst and publisher. He is not a Registered Investment Adviser (RIA), Chartered Financial Analyst (CFA), FINRA-registered sell-side analyst, broker-dealer representative, or licensed portfolio manager. He publishes analysis on securities in his capacity as a journalist and independent researcher under the same First Amendment publication rights available to financial commentators generally. CIN does not manage assets, execute trades, or provide personalized advice.

4. Data Sources & Accuracy

Market data, filings, pricing, and fundamentals on CIN are compiled from primary regulators, exchanges, and institutional feeds across the jurisdictions in our coverage universe. See our Editorial Standards and Methodology pages for our source-class framework.

Although we take reasonable care, we do not warrant the accuracy, completeness, or timeliness of any data, calculation, index score, or commentary published on CIN. Data may be delayed, revised, restated, or withdrawn at any time without notice. Pricing on terminal pages is delayed unless otherwise noted. Fundamentals are refreshed on filing cadence.

5. Forward-Looking Statements

CIN commentary and Insights may contain forward-looking statements — including projections, valuations, scenario analyses, and views on future rescheduling, banking reform, M&A activity, capital flows, or company-specific outcomes. Forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially. Past performance is not indicative of future results. No forward-looking statement should be construed as a guarantee or a promise of any specific outcome.

6. Cannabis-Sector Risk

Cannabis remains a Schedule I controlled substance under U.S. federal law (Controlled Substances Act) and is regulated differently in every jurisdiction CIN covers. Investments in cannabis-related equities involve material and non-standard legal, regulatory, banking, tax (including IRC 280E), enforcement, custodial, and reputational risks that differ from other sectors. Cannabis equities can be volatile and thinly traded, particularly on OTC markets. You are responsible for understanding the legal status of cannabis in your jurisdiction and for complying with all applicable laws.

7. AI-Assisted Content

Portions of CIN's daily briefs, terminal commentary, and research outputs are produced by CIN Voice, our named AI editorial system, and reviewed by human editors before publication. AI-generated content is labeled where required. AI systems may produce analytical errors and are grounded in CIN's structured data inputs; they do not access non-public information. Readers should verify material claims independently before relying on them.

8. Third-Party Content & Links

CIN may link to or cite content from third-party sources including regulatory registries, government statistical agencies, exchanges, and industry publications. CIN does not control and is not responsible for third-party content, and inclusion of a link does not constitute endorsement.

9. Corrections

CIN corrects material errors promptly and discloses the correction on the corrected page. To report an error, email corrections@cannabisinvestornews.co with the URL, the specific claim, and a link to a primary source.

10. Citation & Fair Use

Journalists and researchers may quote briefly from CIN with attribution to "Cannabis Investor News" and a link back to the source page. Byline for quoted analyst commentary reads: "Joseph Farruggia, founder of Cannabis Investor News." For longer excerpts, republication, or licensing, email press@cannabisinvestornews.co.

11. No Warranties · Limitation of Liability

CIN content and services are provided "AS IS" and "AS AVAILABLE" without warranties of any kind, express or implied. To the maximum extent permitted by law, CIN, CanIDeal, and their officers, employees, and agents shall not be liable for any indirect, incidental, special, consequential, or punitive damages, including without limitation loss of profits, revenue, data, or investment losses, arising out of or related to your use of CIN content. See Terms of Service for full terms.

12. Contact

Editorial: editorial@cannabisinvestornews.co · Corrections: corrections@cannabisinvestornews.co · Press & citation: press@cannabisinvestornews.co · Legal: legal@cannabisinvestornews.co.